🏅 FDA Orphan Designation

Lidoderm Patch

Lidocaine patch 5%

Manufacturer: Teikoku Pharma USA, Inc.

Indicated for:

Hereditary sensory and autonomic neuropathy type 5OrphanNON RARE IN EUROPE: Post-herpetic neuralgia

FDA-Approved Indications (2)

Hereditary sensory and autonomic neuropathy type 5Orphan Designation

NON RARE IN EUROPE: Post-herpetic neuralgia

relief of pain associated with post-herpetic neuralgia

Population: all ages

Indications & Usage

INDICATION AND USAGE LIDODERM is indicated for relief of pain associated with post-herpetic neuralgia. It should be applied only to intact skin .

💙 Support Programs

View all →

Lidoderm Patch

Teikoku Pharma USA, Inc.

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.